Your browser is no longer supported. Please, upgrade your browser.
Settings
BLUE [NASD]
bluebird bio, Inc.
Index- P/E- EPS (ttm)-9.95 Insider Own0.60% Shs Outstand66.43M Perf Week-7.78%
Market Cap1.88B Forward P/E- EPS next Y-9.52 Insider Trans-7.62% Shs Float66.04M Perf Month-38.26%
Income-618.70M PEG- EPS next Q-3.03 Inst Own95.30% Short Float9.22% Perf Quarter-37.91%
Sales250.70M P/S7.48 EPS this Y30.50% Inst Trans-1.27% Short Ratio2.96 Perf Half Y-51.72%
Book/sh20.40 P/B1.41 EPS next Y16.60% ROA-33.60% Target Price46.53 Perf Year-60.17%
Cash/sh17.60 P/C1.63 EPS next 5Y- ROE-43.60% 52W Range24.24 - 73.49 Perf YTD-33.72%
Dividend- P/FCF- EPS past 5Y-15.60% ROI-46.00% 52W High-60.97% Beta1.81
Dividend %- Quick Ratio6.00 Sales past 5Y77.90% Gross Margin97.80% 52W Low18.32% ATR2.48
Employees1213 Current Ratio6.00 Sales Q/Q7.00% Oper. Margin- RSI (14)33.59 Volatility7.42% 7.26%
OptionableYes Debt/Eq0.00 EPS Q/Q25.40% Profit Margin- Rel Volume0.83 Prev Close27.94
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.05M Price28.68
Recom2.50 SMA20-17.17% SMA50-31.69% SMA200-46.14% Volume1,708,384 Change2.65%
Feb-17-21Downgrade JP Morgan Overweight → Neutral $76 → $39
Feb-16-21Downgrade William Blair Outperform → Mkt Perform
Feb-16-21Downgrade Wedbush Outperform → Neutral
Feb-16-21Downgrade BofA Securities Buy → Neutral
Dec-09-20Downgrade Maxim Group Buy → Hold
Nov-11-20Initiated Berenberg Buy
Nov-05-20Downgrade Stifel Buy → Hold $77 → $51
Nov-05-20Downgrade BMO Capital Markets Outperform → Market Perform $108 → $56
Nov-05-20Downgrade Barclays Overweight → Equal Weight
Nov-02-20Upgrade William Blair Mkt Perform → Outperform
Oct-20-20Initiated Mizuho Buy $123
May-13-20Initiated RBC Capital Mkts Outperform $100
Mar-27-20Upgrade Stifel Hold → Buy $70
Feb-19-20Downgrade Raymond James Strong Buy → Mkt Perform
Feb-19-20Downgrade Raymond James Outperform → Mkt Perform
Feb-03-20Upgrade Evercore ISI In-line → Outperform $86 → $100
Feb-03-20Resumed BofA/Merrill Buy $120
Dec-13-19Upgrade Oppenheimer Perform → Outperform $135
Nov-26-19Upgrade SVB Leerink Mkt Perform → Outperform $119
Nov-19-19Downgrade Evercore ISI Outperform → In-line $86
Mar-07-21 05:39PM  
Mar-06-21 07:34PM  
02:00PM  
01:01PM  
12:50PM  
Mar-05-21 12:40PM  
12:00PM  
09:27AM  
08:00AM  
06:09AM  
12:20AM  
Mar-04-21 06:15PM  
04:36PM  
01:35PM  
01:00PM  
12:00PM  
11:25AM  
10:45AM  
10:00AM  
Mar-03-21 08:06PM  
06:40PM  
06:00PM  
05:28PM  
04:00PM  
01:45PM  
01:10PM  
07:30AM  
06:30AM  
03:00AM  
Mar-02-21 01:45PM  
01:15PM  
12:30PM  
11:38AM  
11:00AM  
06:13AM  
Mar-01-21 11:54PM  
01:45PM  
12:40PM  
12:00PM  
10:57AM  
09:32AM  
06:30AM  
12:20AM  
Feb-28-21 10:30AM  
01:06AM  
Feb-27-21 02:00PM  
Feb-26-21 08:00AM  
Feb-25-21 04:59PM  
03:00PM  
12:33PM  
11:00AM  
11:00AM  
Feb-24-21 08:26PM  
07:00PM  
05:53PM  
05:30PM  
02:30PM  
02:14PM  
01:19PM  
12:15PM  
12:00PM  
11:15AM  
11:00AM  
11:00AM  
10:24AM  
06:56AM  
Feb-23-21 06:33PM  
05:24PM  
04:05PM  
03:20PM  
02:39PM  
01:37PM  
12:30PM  
12:00PM  
11:15AM  
05:38AM  
Feb-22-21 04:05PM  
02:57PM  
01:22PM  
01:20PM  
12:05PM  
11:55AM  
11:00AM  
11:00AM  
10:16AM  
Feb-21-21 10:30AM  
Feb-20-21 06:45PM  
02:51PM  
07:50AM  
Feb-19-21 01:58PM  
12:30PM  
12:00PM  
11:00AM  
10:55AM  
09:00AM  
08:00AM  
12:05AM  
Feb-18-21 11:59PM  
09:39PM  
06:16PM  
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc., Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc., Gritstone Oncology, Inc., Magenta Therapeutics, Inc., the Seattle Children's Research Institute, University of North Carolina, and the Fred Hutchinson Cancer Research Center. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gregory Philip DChief Scientific OfficerMar 02Sale29.58391,15446,907Mar 04 04:46 PM
Cole JasonChief Operating andMar 02Sale29.58381,12447,997Mar 04 04:46 PM
Davidson DavidChief Medical OfficerMar 02Sale29.58421,24247,829Mar 04 04:46 PM
Obenshain AndrewPresident of SGDMar 02Sale29.58341,00640,166Mar 04 04:46 PM
Leschly NickPresident and CEOMar 02Sale29.5844413,134104,225Mar 04 04:46 PM
Cole JasonChief Operating andFeb 17Sale28.1666518,72748,035Feb 18 05:22 PM
Davidson DavidChief Medical OfficerFeb 17Sale28.1669819,65747,871Feb 18 05:22 PM
Obenshain AndrewPresident of SGDFeb 17Sale28.1674921,09340,200Feb 18 05:22 PM
Gregory Philip DChief Scientific OfficerFeb 17Sale28.1666418,69946,946Feb 18 05:22 PM
Burnett KatyPrincipal Accounting OfficerFeb 17Sale28.1651814,5884,097Feb 18 05:22 PM
Baird William D IIIChief Financial OfficerFeb 17Sale28.1669319,51635,529Feb 18 05:22 PM
Baird William D IIIChief Financial OfficerFeb 12Sale45.521,21655,35221,581Feb 17 05:23 PM
Obenshain AndrewPresident of SGDFeb 02Sale45.93341,56123,884Feb 04 04:04 PM
Gregory Philip DChief Scientific OfficerFeb 02Sale45.93592,71032,948Feb 04 04:03 PM
Cole JasonChief Operating andFeb 02Sale45.93381,74532,785Feb 04 04:03 PM
Leschly NickPresident and CEOFeb 02Sale45.9359427,28086,669Feb 04 04:04 PM
Davidson DavidChief Medical OfficerFeb 02Sale45.93632,89336,298Feb 04 04:04 PM
Leschly NickPresident and CEOJan 06Sale45.0510,095454,81487,263Jan 08 06:18 PM
Smith-Farrell JoanneCOO, OncologyJan 06Sale45.051,28757,98420,609Jan 08 05:56 PM
Cole JasonChief Operating andJan 06Sale45.052,358106,23632,823Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 06Sale45.053,167142,68436,361Jan 08 05:57 PM
FINGER ALISON CECILYChief Commercial OfficerJan 06Sale45.051,81481,72725,103Jan 08 05:57 PM
Baird William D IIIChief Financial OfficerJan 06Sale45.0594942,75622,797Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 06Sale45.052,754124,07733,007Jan 08 05:56 PM
Leschly NickPresident and CEOJan 05Sale44.9533314,96997,358Jan 08 06:18 PM
Smith-Farrell JoanneCOO, OncologyJan 05Sale44.95421,88821,896Jan 08 05:56 PM
Cole JasonChief Operating andJan 05Sale44.95431,93335,181Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 05Sale44.95482,15839,528Jan 08 05:57 PM
FINGER ALISON CECILYChief Commercial OfficerJan 05Sale44.95401,79826,917Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 05Sale44.95452,02335,761Jan 08 05:56 PM
Burnett KatyPrincipal Accounting OfficerDec 03Sale46.091235,6691,460Dec 04 04:49 PM
Davidson DavidChief Medical OfficerDec 02Sale46.20642,95739,576Dec 04 04:48 PM
Gregory Philip DChief Scientific OfficerDec 02Sale46.20592,72635,806Dec 04 04:48 PM
Cole JasonChief Operating andDec 02Sale46.20381,75635,224Dec 04 04:48 PM
Smith-Farrell JoanneCOO, OncologyDec 02Sale46.20381,75621,938Dec 04 04:48 PM
FINGER ALISON CECILYChief Commercial OfficerDec 02Sale46.20361,66326,957Dec 04 04:48 PM
Leschly NickPresident and CEODec 02Sale46.2044420,51297,691Dec 04 04:48 PM
Leschly NickPresident and CEONov 02Sale52.9444423,50698,135Nov 04 04:04 PM
Davidson DavidChief Medical OfficerNov 02Sale52.94633,33539,640Nov 04 04:05 PM
Gregory Philip DChief Scientific OfficerNov 02Sale52.93593,12335,865Nov 04 04:05 PM
Cole JasonChief Operating andNov 02Sale52.97371,96035,262Nov 04 04:05 PM
Smith-Farrell JoanneCOO, OncologyNov 02Sale52.97371,96021,976Nov 04 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerNov 02Sale52.99351,85526,993Nov 04 04:05 PM
Davidson DavidChief Medical OfficerOct 02Sale52.77643,37739,703Oct 06 04:06 PM
Gregory Philip DChief Scientific OfficerOct 02Sale52.77603,16635,924Oct 06 04:05 PM
Leschly NickPresident and CEOOct 02Sale52.7745023,74498,579Oct 06 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerOct 02Sale52.77361,90027,028Oct 06 04:05 PM
Smith-Farrell JoanneChief Business OfficerOct 02Sale52.77382,00522,013Oct 06 04:06 PM
Cole JasonChief Operating andOct 02Sale52.77382,00535,299Oct 06 04:06 PM
Davidson DavidChief Medical OfficerSep 03Sale58.60412,40339,767Sep 08 04:07 PM
Gregory Philip DChief Scientific OfficerSep 03Sale58.60583,39935,984Sep 08 04:08 PM
Cole JasonChief Operating andSep 03Sale58.60362,11035,337Sep 08 04:08 PM
Smith-Farrell JoanneChief Business OfficerSep 03Sale58.60362,11022,051Sep 08 04:08 PM
FINGER ALISON CECILYChief Commercial OfficerSep 03Sale58.60352,05127,063Sep 08 04:08 PM
Leschly NickPresident and CEOSep 03Sale58.6043125,25799,029Sep 08 04:07 PM
Smith-Farrell JoanneChief Business OfficerAug 25Sale58.9522513,26422,087Aug 27 05:11 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerAug 03Sale61.00825,0029,512Aug 05 04:06 PM
Smith-Farrell JoanneChief Business OfficerAug 03Sale60.48372,23822,312Aug 05 04:05 PM
Cole JasonChief Operating andAug 03Sale60.48372,23835,373Aug 05 04:05 PM
Leschly NickPresident and CEOAug 03Sale60.4944426,85699,460Aug 05 04:05 PM
Davidson DavidChief Medical OfficerAug 03Sale60.75422,55239,808Aug 05 04:06 PM
Gregory Philip DChief Scientific OfficerAug 03Sale60.49593,56936,042Aug 05 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerAug 03Sale60.49352,11727,098Aug 05 04:05 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJul 20Sale66.3859639,5629,594Jul 22 05:22 PM
Smith-Farrell JoanneChief Business OfficerJul 02Sale61.57382,34022,349Jul 07 05:17 PM
Leschly NickPresident and CEOJul 02Sale61.5744327,27799,904Jul 07 05:19 PM
Cole JasonChief Operating andJul 02Sale61.57382,34035,410Jul 07 05:18 PM
Davidson DavidChief Medical OfficerJul 02Sale61.57422,58639,850Jul 07 05:22 PM
Gregory Philip DChief Scientific OfficerJul 02Sale61.57593,63336,101Jul 07 05:15 PM
FINGER ALISON CECILYChief Commercial OfficerJul 02Sale61.57362,21727,133Jul 07 05:16 PM
Smith-Farrell JoanneChief Business OfficerJun 04Sale65.2317011,08922,387Jun 08 04:24 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJun 04Sale65.2315410,04510,190Jun 08 04:24 PM
Davidson DavidChief Medical OfficerJun 02Sale64.03422,68939,892Jun 04 05:44 PM
Cole JasonChief Operating andJun 02Sale64.03382,43335,448Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerJun 02Sale64.03372,36922,557Jun 04 05:44 PM
Gregory Philip DChief Scientific OfficerJun 02Sale64.03593,77836,160Jun 04 05:43 PM
FINGER ALISON CECILYChief Commercial OfficerJun 02Sale64.04352,24127,169Jun 04 05:44 PM
Leschly NickPresident and CEOJun 02Sale64.0444428,433100,347Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerMay 04Sale50.1723211,63922,594May 05 04:05 PM
Smith-Farrell JoanneChief Business OfficerApr 06Sale43.7358325,49521,393Apr 08 04:12 PM